Complications and Effectiveness of FDA-Approved Liposuction and Noninvasive Fat Reduction Devices
Andrea Lin, Jocelynne Dorotan, Sameer Patel
Temple University Hospital Fox Chase Cancer Center
内容与影响
BACKGROUND: Liposuction is the fourth most performed cosmetic procedure in the United States, increasing from 211,067 procedures in 2020 to 347,782 in 2023. While the estimated complication rate is 2.4%, long-term outcomes remain understudied. OBJECTIVES: Although FDA-approved devices are advertised to consumers with caution of short-term complications, the known long-term sequelae and overall effectiveness are limited. This study quantifies the frequency and types of complications for the most commonly utilized devices. METHODS: Complaints for 14 FDA-approved liposuction devices-including 5 radiofrequency, 4 laser, 2 ultrasound-assisted, 1 power-assisted, 1 cryosuction, and 1 deoxycholic acid device-from 2020 to 2025 were recorded from the Manufacturer and User Facility Device Experience (MAUDE).The total liposuction procedures documented by the American Society of Plastic Surgeons were obtained from the annual reports 2020-2023 for 6 of these devices. RESULTS: Among 1.8 million procedures, 642 complications were reported (0.04% rate) over the last 5 years. Cryoliposuction accounted for the majority, 72.7% (n = 467/642), with 99% of these complaints linked to paradoxical adipose hyperplasia. Ultrasound-assisted liposuction comprised 13% (n = 84/642), with 54% attributed to machine malfunctions, often due to the liposuction cannula tip breaking off the device (25.5%). Paradoxical rebound (71%) and burns (8.1%) were common. CONCLUSIONS: With less than a 1% estimated complication rate, liposuction devices, regardless of mechanism, is relatively safe. Cryoliposuction and ultrasound devices disproportionately contributed to complaints, suggesting technical error or user challenges. Although ineffectiveness and contour deformity are known long-term complications, paradoxical rebound was the most frequent complaint, potentially influenced by patient expectations of effectiveness.1 These findings highlight the need to examine the use of these devices, assess potential complications, and counsel patients' expectations.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
回答优先基于摘要、文献信息与可获取全文;依据不足时会明确说明。
学术脉络
学科主题
生物医学Body Contouring and Surgery
Lymphatic System and Diseases · Systemic Sclerosis and Related Diseases
参考文献 9
此处列出前 3 条